New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results